Adenosine-induced myocardial vasodilation is improved by C-peptide in Type 1 diabetes

被引：0
|
作者：
Johansson, B
Sundell, J
Ekberg, K
Jonsson, C
Wahren, J
Nuutila, P
Knuuti, J
Raitakari, O
Seppänen, M
Loutolahti, M
机构：
[1] Karolinska Inst, Sect Clin Physiol, Dept Surg Sci, Stockholm, Sweden
[2] Turku Univ Hosp, Turku PET Ctr, FIN-20520 Turku, Finland
[3] Karolinska Inst, Nucl Med Sect, Dept Oncol Pathol, Stockholm, Sweden
[4] Turku Univ Hosp, FIN-20520 Turku, Finland
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
613
引用
收藏
页码：A197 / A198
页数：2
相关论文
共 50 条
  • [21] ADENOSINE-INDUCED VASODILATION - RECEPTOR CHARACTERIZATION IN PULMONARY CIRCULATION
    HAYNES, J
    OBIAKO, B
    THOMPSON, WJ
    DOWNEY, J
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (05): : H1862 - H1868
  • [22] Mechanism of adenosine-induced vasodilation in rat diaphragm microcirculation
    Chen, CW
    Chang, HY
    Hsiue, TR
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (05): : H2210 - H2217
  • [23] FASTING PLASMA C-PEPTIDE, GLUCAGON STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN RELATION TO TYPE OF DIABETES
    GJESSING, HJ
    MATZEN, LE
    FROLAND, A
    DIABETOLOGIA, 1987, 30 (07) : A524 - A524
  • [24] CAFFEINE AND THEOPHYLLINE ATTENUATE ADENOSINE-INDUCED VASODILATION IN HUMANS
    SMITS, P
    LENDERS, JWM
    THIEN, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) : 410 - 418
  • [25] Glyburide inhibits dipyridamole-induced forearm vasodilation but not adenosine-induced forearm vasodilation
    Bijlstra, P
    van Ginneken, EEM
    Huls, M
    van Dijk, R
    Smits, P
    Rongen, GA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (03) : 147 - 156
  • [26] Clinical and molecular pharmacologic characteristics of adenosine-induced vasodilation
    Biaggioni, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (03) : 137 - 139
  • [27] Role of nitric oxide in adenosine-induced vasodilation in humans
    Costa, F
    Biaggioni, I
    HYPERTENSION, 1998, 31 (05) : 1061 - 1064
  • [28] C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes
    Hansen, A
    Johansson, BL
    Wahren, J
    von Bibra, H
    DIABETES, 2002, 51 (10) : 3077 - 3082
  • [29] Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide
    Sima, AAF
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 220 (1-2) : 133 - 136
  • [30] FASTING PLASMA C-PEPTIDE, GLUCAGON STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN RELATION TO CLINICAL TYPE OF DIABETES
    GJESSING, HJ
    MATZEN, LE
    FABER, OK
    FROLAND, A
    DIABETOLOGIA, 1989, 32 (05) : 305 - 311
12345